IL2RA and infection: Well-designed studies in which the total rATG dose was ≤7.5 mg/kg [49, 65, 74] have not indicated any increase in the incidence of infections versus IL-2RA induction other than a higher overall incidence of infection but a lower rate of CMV infection under rATG in the study by Brennan et al. [49].